North Capital’s Sanofi SNY Stock Holding History

North Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-107	Closed	-$5.05K	–	604
2025 Q3	$5.05K	Hold	107	–	–	﹤0.01%	439
2025 Q2	$5.17K	Sell	107 -17	-14%	-$869	﹤0.01%	440
2025 Q1	$6.88K	Buy	+124	New	+$6.71K	0.01%	403

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

North Capital's SNY Position: Q4 2025 in Review

North Capital sold out of Sanofi (SNY) in Q4 2025, closing a stake of 107 shares — an estimated $5.05K sold.

North Capital first reported a position in SNY in Q1 2025 and held it in 3 quarters. The position peaked at $6.88K in Q1 2025. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

North Capital reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
North Capital sold 107 Sanofi shares in Q4 2025, an estimated $5.05K.
North Capital first reported a position in Sanofi in Q1 2025 and held it in 3 quarters.
North Capital's Sanofi position peaked at $6.88K in Q1 2025.
757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.